Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of Ablative Stereotactic MR-Guided Adaptive Reirradiation for Abdominal and Pelvic Tumors

NCT06397573 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT06397573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06397573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of Ablative Stereotactic MR-Guided Adaptive Reirradiation for Abdominal and Pelvic Tumors
Lead sponsor
Baptist Health South Florida
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 5, 2024
Completion date
June 30, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal cancer, pelvic cancer